The novel drug class of Glucagon-like peptide-1 ( GLP-1 ) analogue is extremely promising,since they can address many of the unmet needs of diabetes treatment. This article summarized physiological action of GLP-1 and delayed mechanisms of long-acting human GLP-1 analogue liraglutide. Simultaneously, the latest basic and clinical research results of liraglutide were reported especially.
Key words:
Glucagon-like peptide-1 ; Liraglutide ; Diabetes,type 2 ;